Nat Rev Drug Discov. 2002 Sep;1(9):710-26.

Pharmacotherapy of addictions.

Source

Laboratory of the Biology of Addictive Diseases, Rockefeller University, 1230 York Avenue, New York, New York 10021, USA. kreek@mail.rockefeller.edu

Erratum in

Nat Rev Drug Discov 2002 Nov;1(11):920.

Abstract

Addiction to drugs, such as heroin, cocaine and alcohol, exacts great human and financial costs on society, but the development of pharmacotherapies for addiction has been largely neglected by the pharmaceutical industry. With advances in our understanding of the underlying biology of addictions now opening the door for the development of novel pharmacotherapies, it could be time for a reassessment of involvement in this increasingly important therapeutic area. Here, we summarize the current approved and implemented pharmacotherapeutic approaches to the treatment of addiction, and then highlight the most promising areas for future drug development from the perspective of our laboratory and our National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) Research Center.

PMID:: 12209151; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Review Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002. [Issue Brief Health Policy Trac...]
Review Behavioral health issue brief: pharmacotherapy treatment of alcoholism and drug addiction: overview and bibliography: year end report-2002.
Colker AC. Issue Brief Health Policy Track Serv. 2002 Dec 31; :1-6.
Review Addiction pharmacotherapy 2000: new options, new challenges. [J Psychoactive Drugs. 2000]
Review Addiction pharmacotherapy 2000: new options, new challenges.
Rawson RA, McCann MJ, Hasson AJ, Ling W. J Psychoactive Drugs. 2000 Oct-Dec; 32(4):371-8.
Review Pharmacogenetic treatments for drug addiction: alcohol and opiates. [Am J Drug Alcohol Abuse. 2008]
Review Pharmacogenetic treatments for drug addiction: alcohol and opiates.
Haile CN, Kosten TA, Kosten TR. Am J Drug Alcohol Abuse. 2008; 34(4):355-81.
Review [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine]. [Actas Esp Psiquiatr. 2003]
Review [Pharmacological treatment of substance dependence from a neuroscientific perspective (I): opiates and cocaine].
Haro G, Cervera G, Martínez-Raga J, Pérez-Gálvez B, Fernández-Garcés M, Sanjuan J. Actas Esp Psiquiatr. 2003 Jul-Aug; 31(4):205-19.
Review Pharmacologic treatments for heroin and cocaine dependence. [Am J Addict. 2003]
Review Pharmacologic treatments for heroin and cocaine dependence.
Kleber HD. Am J Addict. 2003; 12 Suppl 2:S5-S18.

See reviews... See all...

Cited by 34 PubMed Central articles

Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors. [Neurochem Res. 2011]
Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors.
Lee CW, Yan JY, Chiang YC, Hung TW, Wang HL, Chiou LC, Ho IK. Neurochem Res. 2011 Nov; 36(11):2008-21. Epub 2011 Jun 14.
1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor Antagonists. [ACS Med Chem Lett. 2010]
1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor Antagonists.
Carroll FI, Cueva JP, Thomas JB, Mascarella SW, Runyon SP, Navarro HA. ACS Med Chem Lett. 2010 Oct 14; 1(7):365-369.
Review Drug addiction. [Curr Top Behav Neurosci. 2009]
Review Drug addiction.
Justinova Z, Panlilio LV, Goldberg SR. Curr Top Behav Neurosci. 2009; 1:309-46.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Recent activity

Clear Turn Off Turn On

Pharmacotherapy of addictions.
Pharmacotherapy of addictions.
Nat Rev Drug Discov. 2002 Sep ;1(9):710-26.

PubMed
Clinical proteomics: translating benchside promise into bedside reality.
Clinical proteomics: translating benchside promise into bedside reality.
Nat Rev Drug Discov. 2002 Sep ;1(9):683-95.

PubMed
Computational prediction of eukaryotic protein-coding genes.
Computational prediction of eukaryotic protein-coding genes.
Nat Rev Genet. 2002 Sep ;3(9):698-709.

PubMed
IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance.
IgE to Bet v 1 and profilin: cross-reactivity patterns and clinical relevance.
J Allergy Clin Immunol. 2002 Sep ;110(3):435-42.

PubMed
Theoretical perspectives of postpartum depression and their treatment implicatio...
Theoretical perspectives of postpartum depression and their treatment implications.
MCN Am J Matern Child Nurs. 2002 Sep-Oct ;27(5):282-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: